Goodness Growth Holdings Inc (GDNSF)
0.44
+0.02
(+4.76%)
USD |
OTCM |
Jun 21, 16:00
Goodness Growth Holdings Profit Margin (Quarterly): -27.86% for March 31, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -27.86% |
| December 31, 2023 | -18.96% |
| September 30, 2023 | -21.19% |
| June 30, 2023 | -36.29% |
| March 31, 2023 | -44.04% |
| December 31, 2022 | -69.76% |
| September 30, 2022 | -44.68% |
| June 30, 2022 | -29.32% |
| March 31, 2022 | -93.15% |
| December 31, 2021 | -94.69% |
| September 30, 2021 | -51.39% |
| Date | Value |
|---|---|
| June 30, 2021 | -49.27% |
| March 31, 2021 | -52.14% |
| December 31, 2020 | -18.27% |
| September 30, 2020 | 23.66% |
| June 30, 2020 | -131.9% |
| March 31, 2020 | -62.00% |
| December 31, 2019 | -345.4% |
| September 30, 2019 | -204.1% |
| June 30, 2019 | -27.75% |
| March 31, 2019 | -59.66% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-345.4%
Minimum
Dec 2019
23.66%
Maximum
Sep 2020
-69.93%
Average
-46.98%
Median
Profit Margin (Quarterly) Benchmarks
| Acasti Pharma Inc | -- |
| Aurinia Pharmaceuticals Inc | -59.60% |
| Edesa Biotech Inc | -- |
| Lexaria Bioscience Corp | -448.0% |
| Xenon Pharmaceuticals Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -13.70% |
| Return on Invested Capital | -45.54% |
| Gross Profit Margin (Quarterly) | 50.83% |
| Operating Margin (Quarterly) | 19.76% |
| Return on Net Operating Assets | -28.94% |